Related Experiment Video
Updated: Jun 6, 2026

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
Published on: November 11, 2021
[Recurrent and metastatic infantile fibrosarcoma: a case report]
M Lagree1, F Toutain, Y Revillon
1Service d'hémato-oncologie pédiatrique, CHU Charles-Nicolle, 1 rue de Germont, Rouen cedex, France.
Insights
Infantile fibrosarcoma, a rare infant tumor, can be misdiagnosed as benign. Early detection via ETV6/NTRK3 fusion transcript is crucial for effective treatment and remission.
Area of Science:
- Pediatric Oncology
- Surgical Pathology
- Molecular Diagnostics
Background:
- Infantile fibrosarcoma is a rare pediatric malignancy, typically presenting in infants under one year.
- It comprises 5-10% of infant sarcomas and usually exhibits indolent behavior with rare metastasis.
Observation:
- A case of infantile fibrosarcoma of the trunk is presented, initially misdiagnosed as an angioma.
- The patient experienced an uncommon aggressive progression with three metastatic relapses.
Findings:
- Diagnosis was confirmed by the ETV6/NTRK3 fusion transcript, indicative of the t(12;15)(p13;q25) translocation.
- The patient achieved persistent complete remission through a multimodal approach including surgery, chemotherapy, and radiation therapy.
Implications:
- Highlights the diagnostic challenge between infantile fibrosarcoma and benign vascular tumors in neonates.
- Emphasizes the utility of molecular diagnostics (ETV6-NTRK3 fusion) for accurate infantile fibrosarcoma diagnosis.
- Discusses treatment strategies, including the role of neoadjuvant chemotherapy and debated use of radiation therapy.
Abstract:
Infantile fibrosarcoma is a rare malignant tumor that usually occurs during the 1st year of life. It accounts for approximately 5-10% of all sarcomas in infants younger than 1 year of age. It usually has indolent progression and metastatic spread is rare. We report the case of a patient who had infantile fibrosarcoma of the trunk. At birth, the baby presented a soft tissue mass of the scapulothoracic region. Histopathological examination after complete surgical resection at first suggested an angioma. Reanalysis of the histology after a metastatic relapse resulted in the diagnosis of infantile fibrosarcoma, which was confirmed by the presence of the specific translocation seen in infantile fibrosarcoma (ETV6/NTRK3). This patient's progression was uncommon because he developed 3 metastatic relapses. The treatment consisted of surgery, chemotherapy, and radiation therapy. The patient is alive with persistent complete remission. We discuss the diagnostic and therapeutic issues of infantile fibrosarcoma. There is a risk of erroneous diagnosis in newborn infants between benign angiomatous tumor and infantile fibrosarcoma. The fusion transcript ETV6-NTRK3 resulting from the specific chromosomal translocation t(12;15)(p13;q25) is now a useful diagnostic tool for infantile fibrosarcoma. Surgery with wide resection is the mainstay of treatment. However, infantile fibrosarcoma is a chemosensitive tumor. If initial surgery cannot be done without mutilation or is impossible, preoperative chemotherapy should be given. The role of radiation therapy is still debated.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
